Patents by Inventor Ajay Ghanta

Ajay Ghanta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSDERMAL CREAM
    Publication number: 20190070197
    Abstract: This disclosure relates to transdermal pharmaceutical compositions containing progesterone in combination with one or more solubilizing agents and penetration enhancers, wherein the pharmaceutical compositions are formulated as creams for topical administration. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, and d-limonene. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, a penetration enhancer (e.g., propylene glycol, a fatty acid ester of propylene glycol, a glycol ether), and optionally d-limonene. In certain embodiments, the pharmaceutical compositions further include estradiol. Methods for treating conditions associated with hormone deficiency in a subject are also described.
    Type: Application
    Filed: September 7, 2018
    Publication date: March 7, 2019
    Inventors: JULIA AMADIO, ANNETTE SHADIACK, PETER H.R. PERSICANER, RICHARD WINNEKER, JASON LEGASSIE, THORSTEINN THORSTEINSSON, AJAY GHANTA
  • Transdermal cream
    Patent number: 10098894
    Abstract: This disclosure relates to transdermal pharmaceutical compositions containing progesterone in combination with one or more solubilizing agents and penetration enhancers, wherein the pharmaceutical compositions are formulated as creams for topical administration. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, and d-limonene. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, a penetration enhancer (e.g., propylene glycol, a fatty acid ester of propylene glycol, a glycol ether), and optionally d-limonene. In certain embodiments, the pharmaceutical compositions further include estradiol. Methods for treating conditions associated with hormone deficiency in a subject are also described.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: October 16, 2018
    Assignee: TherapeuticsMD, Inc.
    Inventors: Julia Amadio, Annette Shadiack, Peter H. R. Persicaner, Richard Winneker, Jason Legassie, Thorsteinn Thorsteinsson, Ajay Ghanta